14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PRQR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ProQR Therapeutics N.V. stock upgraded from Sell Candidate to Hold/Accumulate after Tuesday trading session.
(Updated on Apr 23, 2024)

Hold candidate since Apr 23, 2024 PDF

The ProQR Therapeutics N.V. stock price gained 1.00% on the last trading day (Tuesday, 23rd Apr 2024), rising from $2.00 to $2.02. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.52% from a day low at $1.99 to a day high of $2.12. The price has fallen in 6 of the last 10 days and is down by -15.48% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 74 thousand more shares were traded than the day before. In total, 176 thousand shares were bought and sold for approximately $355.71 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.23% during the next 3 months and, with a 90% probability hold a price between $1.94 and $2.71 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PRQR Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 8.60%. Further rise is indicated until a new top pivot has been found. ProQR Therapeutics N.V. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The ProQR Therapeutics N.V. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.19. On a fall, the stock will find some support from the short-term average at $1.97. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for ProQR Therapeutics N.V. stock

ProQR Therapeutics N.V. finds support from accumulated volume at $1.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.130 between high and low, or 6.52%. For the last week, the stock has had daily average volatility of 9.35%.

Our recommended stop-loss: $1.94 (-4.08%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (PRQR) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect ProQR Therapeutics N.V. to open at $2.04, and during the day (based on 14 day Average True Range), to move between $1.85 and $2.19, which gives a possible trading interval of +/-$0.169 (+/-8.38%) up or down from last closing price. If ProQR Therapeutics N.V. takes out the full calculated possible swing range there will be an estimated 16.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.09 (3.47%) than the support at $1.95 (3.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ProQR Therapeutics N.V. stock A Buy?

ProQR Therapeutics N.V. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.586 Hold/Accumulate Upgraded

Predicted Opening Price for ProQR Therapeutics N.V. of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$2.04 ( 1.16%) $2.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PRQR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.17 7.58 %
R2 2.12 5.13 %
R1 2.09 3.61 %
Current price: 2.02
Support S1 1.99 -1.30 %
S2 1.96 -2.81 %
S3 1.91 -5.27 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.33 15.35 %
R2 2.20 8.91 %
R1 2.09 3.47 %
Current price 2.02
Support S1 1.95 -3.47%
S2 1.93 -4.46%
S3 1.90 -5.94%

FAQ

What is the symbol for ProQR Therapeutics N.V. Stock and on which exchange is it traded?
The symbol for ProQR Therapeutics N.V. is PRQR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProQR Therapeutics N.V. Stock.

What's the current price of ProQR Therapeutics N.V. Stock?
As of the end of day on the Apr 23, 2024, the price of an ProQR Therapeutics N.V. (PRQR) share was $2.02.

What is the 52-week high and low for ProQR Therapeutics N.V. Stock?
The 52-week high for ProQR Therapeutics N.V. Stock is $3.29 and the 52-week low is $1.11.

What is the market capitalization of ProQR Therapeutics N.V. Stock?
As of the Apr 23, 2024, the market capitalization of ProQR Therapeutics N.V. is 163.251M.

When is the next earnings date for ProQR Therapeutics N.V.?
The upcoming earnings date for ProQR Therapeutics N.V. is May 21, 2024.
Click to get the best stock tips daily for free!

About ProQR Therapeutics N.V.

ProQR Therapeutics N.V. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in... PRQR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT